Low molecular weight heparin vs UFH
Incidence of recurrent VTE1 after initial treatment (up to 15 days) · patients with venous thromboembolism.
LMWH probably leads to lower incidence of recurrent VTE1 after initial treatment (up to 15 days) compared with UFH (moderate certainty).
1 finding from 1 review
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes onlyOR 0.69 [0.49, 0.98]18 studies · 6238 participantsModerate